10 | 20240423 | Material Management Information related to Judgment of Investment(진행성 췌장암 환자에서 자연살해세포와 mFOLFIRINOX 병합치료의 임상 2a상 연구 임상시험계획 신청 반려) | |
9 | 20240327 | Outcomes of Annual Meeting of Shareholders | |
8 | 20240315 | Submission of Audit Report | |
7 | 20240214 | [Revised]Resolutions for Convocation of General Meeting of Shareholders | |
6 | 20240213 | [Revised]Material Management Information related to Judgment of Investment(YBL-007 기술도입계약 체결의 건) | |
5 | 20240213 | Resolutions for Convocation of General Meeting of Shareholders | |
4 | 20240213 | Material Management Information related to Judgment of Investment(YBL-007 기술도입계약 체결의 건) | |
3 | 20240207 | 30% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations) | |
2 | 20231127 | Additional Listing(무상증자) | KOSDAQ STOCK MKT. |
1 | 20231120 | Additional Listing(유상증자(구주주배정)) | KOSDAQ STOCK MKT. |